Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook
Teladoc Health shares slid in Thursday's premarket after Q2 results and a cautious outlook tempered its earnings outlook.
Teladoc Health reported Q2 results, but told investors it might grow more slowly in Q3 than expected. When companies warn that future growth could be weak, stock prices usually drop because investors get nervous about what's ahead.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.